Bath & Body Works Surges on Stock Recommendation; Klarna Drops on Guidance

Stock markets showed mixed movements with Bath & Body Works surging on a positive analyst upgrade from Citi, while Klarna declined despite posting a profit beat due to missed revenue guidance attributed to foreign exchange headwinds and German market challenges. Meanwhile, Amylyx Pharmaceuticals rallied significantly after its experimental drug for post-bariatric surgery low blood sugar demonstrated positive late-stage trial results.